Sage Journals: Discover world-class research

Open access

Case report

First published 2023

IgG3 Antibody Response to COVID-19 Vaccination in a Patient With a Large Heavy Chain Deletion

Sandeep Sarkaria, Zachary Hostoffer, Meghan Callahan [...]

Therapeutic Advances in Allergy and Rhinology

Retricted access

Research article

First published 2013-04

DHFR 19-bp Deletion and SHMT C1420T Polymorphisms and Metabolite Concentrations of the Folate Pathway in Individuals with Down Syndrome

Cristiani Cortez Mendes, Aline Maria Zanchetta de Aquino Raimundo, Luciana Dutra Oliveira [...]

Genetic Testing and Molecular Biomarkers

Open access

Case report

First published 2025

Prolonged response to osimertinib in three patients with refractory metastatic pancreatic adenocarcinomas with EGFR exon 19 deletion: a case report and literature review

Timothée Vigié, Alexandre Perrier, Brice Chanez [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2022

The Biological Causes and Consequences of COVID-19: ACE I/D Polymorphism and In-Silico Screening of Potential Bioactive Phytochemicals Against COVID-19

Nageen Hussain, Muhammad Adil, Mohsin Mumtaz [...]

Bioinformatics and Biology Insights

Open access

Research article

First published 2023

Relationship between Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism and the Risk of COVID-19: A Meta-Analysis

Hu Luoyi, Pan Yan, Fan Qihong

Journal of the Renin-Angiotensin-Aldosterone System

Retricted access

Research article

First published 2016-01

Chromogenic Assay for Lung Cancer-Related EGFR Exon 19 Hotspot Deletion Mutations

Andy K. Zhang

Genetic Testing and Molecular Biomarkers

Open access

Research article

First published 2023

Rationale and design of phase II clinical trial of dual inhibition with ramucirumab and erlotinib in EGFR exon 19 deletion-positive treatment-naïve non-small cell lung cancer with high PD-L1 expression (SPIRAL-3D study)

Hayato Kawachi, Tadaaki Yamada, Akihiro Yoshimura [...]

Therapeutic Advances in Medical Oncology

Retricted access

Review article

First published 2016-6

Tyrosine kinase inhibitors for epidermal growth factor receptor gene mutation–positive non-small cell lung cancers: an update for recent advances in therapeutics

Clement Chung

Journal of Oncology Pharmacy Practice

Open access

Case report

First published 2023

A case of epidermal growth factor receptor tyrosine kinase inhibitor effectiveness in epidermal growth factor receptor mutation-positive squamous cell carcinoma

Sosuke Matsumura, Satoshi Ano, Norihiro Kikuchi [...]

Sage Open Medical Case Reports

Retricted access

Research article

First published 2008-12

Human Telomerase Reverse Transcriptase Promoter-Driven Oncolytic Adenovirus with E1B-19 kDa and E1B-55 kDa Gene Deletions

Joshua C. Doloff, David J. Waxman, Youssef Jounaidi

Human Gene Therapy

Search results